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INTRODUCTION
Over a decade ago, the Institute of Medicine (IOM) released 
three reports on the future of emergency medicine (EM) in the 
United States (US).1-3 Those reports called for: 1) enhancing EM 
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Introduction: Promoting emergency medicine (EM) clinical trials research remains a priority. To 
characterize the status of clinical EM research, this study assessed trial quality, funding source, and 
publication of EM clinical trials and compared EM and non-EM trials on these key metrics. We also 
examined the volume of EM trials and their subspecialty areas. 
Methods: We abstracted data from ClinicalTrials.gov (February 2000 - September 2013) and used 
individual study National Clinical Trial numbers to identify published trials (January 2007 - September 
2016). We used descriptive statistics and chi-square tests to examine study characteristics by EM and 
non-EM status, and Kaplan-Meier curves and log-rank tests to compare time to publication of completed 
EM and non-EM studies.
Results: We found 638 interventional EM trials and 59,512 non-EM interventional trials conducted in the 
United States between February 2000 and September 2013, registered on ClinicalTrials.gov. EM studies 
were significantly less likely than non-EM studies to be National Institutes of Health-funded or to evaluate 
a drug or biologic. However, EM studies had significantly larger sample sizes, and were significantly 
more likely to use randomization and blinding. Overall, 34.3% of EM and 26.0% of non-EM studies were 
published in peer-reviewed journals. By subspecialty, more EM trials concerned medical/surgical and 
psychiatric/neurological conditions than trauma. 
Conclusion: Although EM studies were less likely to have received federal or industry funding, and the 
EM portfolio consisted of only 638 trials over the 14-year study period, the quality of EM trials surpassed 
that of non-EM trials, based on indices such as randomization and blinding. This novel finding bodes 
well for the future of clinical EM research, as does the higher proportion of published EM than non-EM 
trials. Our study also revealed that trauma studies were under-represented among EM studies. Periodic 
assessment of EM trials with the metrics used here could provide an informative and valuable longitudinal 
view of progress in clinical EM research. [West J Emerg Med. 2020;21(2)295-303.] 
and trauma care research through additional federal funding; 
2) assessing research needs, gaps, and opportunities; and 3) 
encouraging academic medical centers to provide research time 
and facilities.4-5 Those recommendations prompted roundtable 
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Population Health Research Capsule
What do we already know about this issue?
Efforts to advance rigorous emergency medicine 
(EM) clinical trials continue, but little is known 
about the current quality and characteristics of 
this research.
What was the research question?
Using ClinicalTrials.gov and PubMed data, how 
do EM and non-EM trials compare on funding, 
quality and publication of results?
What was the major finding of the study?
EM studies had less federal/industry funding, 
but their quality and likelihood of publication 
surpassed non-EM trials.
How does this improve population health?
We identified key metrics for monitoring and 
improving EM research. This paves the way 
for strengthening the EM evidence base and 
enhancing patient care.
discussions focused on advancing research in three broad areas: 
trauma; neurological and psychiatric emergencies; and surgical or 
medical emergencies.6  
In light of these reports and recommendations, we aimed to 
characterize the status of clinical EM research and to compare 
EM with non-EM studies. We restricted our assessment to 
clinical trials, essential components of evidence-based medicine 
and of interest to the National Institutes of Health (NIH), which 
promotes funding opportunities for high-quality, multisite 
EM trials.7 We based our assessment on several metrics: study 
quality; funding source; and dissemination of study findings. 
These metrics provide quantifiable measures of clinical 
EM research that can be used going forward to evaluate the 
characteristics and productivity of this research over time. In 
addition, we examined the distribution of trials across EM 
subspecialties (neurological/psychiatric, trauma, medical-
surgical), which may help to direct funding to under-researched 
areas, and we examined the volume of EM registered trials by 
year and funding source, to assess trends.
We identified trials through ClinicalTrials.gov,8 which 
is the largest online trial registration and results reporting 
repository in the world and includes studies across medical 
disciplines.9 As trial registration is required at the time of study 
enrollment, ClinicalTrials.gov includes published and non-
published studies, thereby providing a comprehensive listing 
of initiated trials. We used this information to compare EM and 
non-EM studies on the metrics of interest identified above, and 
to conduct EM-specific analyses on subspecialty and trends in 
registration. For dissemination of study findings, we examined 
whether the EM and non-EM trials registered in ClinicalTrials.
gov were published in peer-reviewed journals. 
METHODS
Data Abstraction
We abstracted data from the publicly available Aggregate 
Analysis of ClinicalTrials.gov (AACT) database, a relational 
database with multiple tables of downloadable data, provided by 
the Clinical Trials Transformation Initiative, to facilitate analysis 
of trial data registered in ClinicalTrials.gov.10 We restricted our 
search to studies conducted in the US and downloaded data on 
trials registered from the inception of the ClinicalTrials.gov 
website (February 2000) until September 2013.
Search Strategy for Eligible EM and non-EM Trials in 
ClinicalTrials.gov
To identify potential EM studies, we first conducted an 
automated keyword search of the title and brief and detailed 
description fields of each study’s ClinicalTrials.gov record 
that was included in the AACT database We searched for the 
following terms: 1) emergency; 2) ER; 3) ED; 4) EM; and 
5) acute care. Then, ClinicalTrial.gov administrators at our 
institution with expertise in protocol review and registration (JR, 
JD, AO, MW) manually reviewed these studies to identify which 
were truly EM studies, defined as studies that took place in the 
EM setting or studies that addressed medical issues related to 
EM. Initially, these administrators examined a subset of studies 
and collectively discussed and resolved any classification issues. 
Remaining studies were evaluated by one of these individuals 
using standardized criteria.
Once the initial set of EM studies was identified, we used a 
machine learning algorithm based on the study title and brief and 
detailed description fields to build a text classifier that categorized 
EM and non-EM studies automatically. For studies identified as 
non-EM based on the keyword search above, we conducted a 
keyword search for “trauma” to search for additional EM studies. 
We applied the text classifier separately to studies that did and 
did not match on “trauma.” For each study, the text classifier 
generated an estimated probability of being an EM study. For 
each group based on keyword “trauma,” we sorted the studies by 
estimated probability, and stopped the searches after observing 
no EM studies below an estimated probability cutoff significantly 
lower than 1%. We then manually reviewed the studies with 
the highest EM study probability to determine whether any 
met criteria for inclusion as EM studies. We further narrowed 
our inclusion criteria for identified EM and non-EM studies to 
interventional trials, using the “study design” field in the AACT 
database to exclude observational studies. 
Variables
We included the following measures of study characteristics 
and quality that we extracted from the AACT database: 1) study 
phase; 2) intervention type; 3) sample size; 4) randomization; and 
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5) blinding. Following the methods described by Goswami and 
colleagues,11 we derived funding source from AACT database 
variables: 1) “agency” (NIH, US federal, industry, other); and 2) 
“sponsor type” (lead sponsor and collaborators). We categorized 
funding, based on the sponsor, as the following: 1) industry; 2) 
NIH and US federal funding; and 3) “other.” 
We manually categorized EM interventional studies by 
research topic using the NIH Task Force on Research in the 
Emergency Setting criteria.6 We used AACT database fields 
“official title,” and the study’s “detailed description” to designate 
the research topic. Initially, two raters (JR and MW) categorized 
each study. Across 17 studies, chance-adjusted agreement was қ = 
.79. The original raters then trained one additional rater (AO) and 
one of these raters then examined each of the remaining studies. 
Raters could include a study under more than one substantive 
area, if appropriate.  
Identifying Published Studies
We turned to the published literature to assess 
dissemination because federal law requires that only a subset 
of registered trials report results in ClinicalTrials.gov, ie, 
applicable clinical trials that include investigations of a drug or 
biologic other than phase 1; investigations of Food and Drug 
Administration-regulated devices other than small feasibility 
studies and some studies of prototype devices; and pediatric 
post-market surveillance of devices.12 
In July 2005, the National Library of Medicine began 
including the NCT number in the MEDLINE record when it was 
included in the published paper.13 Also in 2005, the International 
Committee of Medical Journal Editors began requiring trial 
registration as a condition of publication.14 Hence, we assumed 
a more complete listing of registered trials beginning in 2005. 
We began our search for publications with trials completed in 
January 2007 as we assumed that trials registered in 2005 would 
take at least two years to complete. We based this assumption on 
a review of a subset of studies registered in ClinicalTrials.gov by 
our institution where the average time from registration to study 
completion was 2.9 years. We included all studies completed 
up to the final date of data abstraction, September 27, 2013. We 
followed these completed studies through September 30, 2016, 
thus providing a minimum follow-up of three years to determine 
whether the study had been published. 
To identify completed studies, we used the “study 
completion date” provided in ClinicalTrials.gov; if the study was 
missing that date but had a “primary completion date,” we used 
the latter. We used the same criteria to identify EM and non-EM 
published studies, ie, matching the unique ClinicalTrials.gov 
National Clinical Trial (NCT) identifier to the study’s MEDLINE 
record in PubMed.  
Statistical Analyses
To compare EM and non-EM studies on study characteristics 
and quality, funding source, and publications, we used descriptive 
statistics and chi-square tests. We compared time to publication 
for EM and non-EM studies using Kaplan-Meier curves and 
log-rank tests. We also used Kaplan-Meier methods to compare 
differences in time to publication for EM and non-EM studies 
stratified by funding source and study phase. We considered 
unpublished studies censored at the final date of potential 
publication, September 30, 2016. We conducted two EM-specific 
analyses: trends in EM trial registration by funding source and 
year (2000-2013), and proportions of EM trials in three sub-
specialties (trauma, neurological and psychiatric emergencies, 
and surgical or medical emergencies). We used frequency 
distributions for these analyses. 
We used SAS software, version 9.3 of the SAS System for 
Windows, copyright 2002-2012 (SAS Institute Inc., Cary, NC) 
for the initial search for EM and non-EM studies, for descriptive 
statistics, and for comparisons between EM and non-EM studies 
on trial characteristics. We used R: A Language and Environment 
for Statistical Computing, version 3.3.0, (R Foundation for 
Statistical Computing, Vienna, Austria) to develop the automatic 
text classifier, and to determine time to publication. 
RESULTS
Identification of Emergency Medicine Trials
As shown in Figure 1, there were over 72,000 US studies 
registered between January 2000 and September 2013. The first 
keyword search on emergency terms yielded 2,735 studies, which 
we used to develop the automatic text classifier. Using the text 
classifier and manual review as shown in the figure, we identified 
a total of 898 EM studies. Omitting observational studies, we 
found 638 interventional EM trials conducted in US-registered 
in ClinicalTrials.gov to September 27, 2013 and we identified 
59,512 non-EM interventional trials conducted in the US during 
the same period. 
Characteristics and Quality of Registered Trials 
Table 1 shows significant differences between EM and non-
EM trials on study characteristics and indices of trial quality. 
More non-EM than EM trials evaluated a drug/biologic (74.2% 
vs 46.1%). EM trials were more likely to evaluate procedural, 
device, or behavioral interventions. Only about half of all EM 
trials reported any study phase, compared with three quarters 
of non-EM trials and fewer EM (45.6%) than non-EM studies 
(51.3%) were phase 2 or higher; thus, more non-EM trials met 
criteria for applicable clinical trials that required study results 
reporting. With respect to trial quality, EM studies were more 
likely to be randomized, to use blinding, and to have larger 
sample sizes. Among EM studies, 59% were classified as 
medical/surgical trials, 36% as neurological/psychiatric, and 17% 
as trials involving trauma patients. These proportions sum to 
greater than 100% and indicate that some trials investigated more 
than one substantive area. 
Funding
Table 1 also shows significant differences between EM 
and non-EM trials on funding source. Whereas 32.3% and 
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41.4% of non-EM trials were funded by the NIH or by industry, 
respectively; only 23.7% and 17.1% of EM trials were funded 
by these sources. Figure 2 displays registered EM clinical 
trials by year and funding. A marked increase in the number of 
registered trials occurred in 2005, the first year investigators 
registered trials that were funded by sources other than industry 
or government. Between 2007 and 2013 EM trial registration 
was fairly stable, with 65-87 newly registered trials per year. 
Throughout that period, EM studies continued to be dominated 
by “other” sources of funding. 
Publication of Trial Results
Between September 27, 2007, and September 30, 2016, 216 
of 638 EM registered trials were completed (Table 2). Based on 
linking trial registration number with the PubMed record, we 
found that 74 (34.3%) of those studies were published in peer-
reviewed journals three or more years after completion. Among 
non-EM studies, 5788 (26.0%) were published during that time 
frame. Of all completed studies, 97.7% of EM and 92.7% of 
non-EM studies had a study completion date in ClinicalTrials.
gov. Among those, the proportions of EM and non-EM studies 
that were published within one year were 6.6% and 4.4%, 
respectively. At two years, 18.0% of EM and 11.9% of non-EM 
studies had been published in peer-reviewed journals.
Overall, EM studies were more likely than non-EM studies 
to be published (p = 0.011; Figure 3a). By funding source, 
Figure 1. Emergency medicine (EM) and non-EM clinical trials inclusion flow chart.
ED, emergency department; ER, emergency room.
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NIH-funded EM studies were more likely than NIH-funded 
non-EM studies to be published (p<0.01; figure 3b). However, 
among industry- and other-funded studies, publication of EM 
and non-EM studies did not differ (Figures 3c-3d). In addition, 
publication of EM and non-EM studies did not differ by study 
phase (data not shown).
DISCUSSION
Among US clinical trials registered in ClinicalTrials.gov, 
we found significant differences between EM and non-EM on 
trial characteristics and quality measures, funding sources, and 
dissemination of results through publication. Regarding trial 
characteristics, fewer EM than non-EM trials identified a study 
phase. This is consistent with our finding that fewer EM than non-
EM trials assessed drug and biologic interventions; trials without 
phases typically assess behavioral interventions or devices. On 
measures of trial quality, EM compared favorably with non-EM 
trials; they were more likely to be randomized, to employ single 
or double blinding, and to include larger sample sizes. However, 
although of significantly higher quality, fewer EM than non-EM 
trials in our study received funding from industry or NIH and 
other federal agencies. There is broad consensus, dating back to 
the 2006 IOM reports, that there is a need to increase the conduct 
of EM clinical trials to expand the overall EM evidence base,4 
and that increased funding is needed to meet that goal.6, 15 The 
good quality of EM studies that we observed suggests that EM 
is well positioned to increase its base of funded studies. Indeed, 
the number of EM projects submitted to NIH has increased in 
recent years.17 Still, the number of NIH-funded projects remains 
low compared with other medical specialties.16 For example, 
Study characteristic
Emergency medicine trials 
(n = 638)
Number (%)
Non-emergency medicine trials 
(n = 59,512)
Number (%) P-value
Funding source <0.001
National Institutes of Health/US federal 151 (23.7) 19,197 (32.3)
Industry 109 (17.1) 24,309 (41.4)
Other 378 (59.3) 16,006 (26.9)
Phase <0.001
N/A 310 (48.6) 14,614 (24.6)
Phase 0-1 37 (5.8) 14,337 (24.0)
Phase 2 106 (16.6) 17,052 (28.6)
Phase 3 79 (12.4) 8,454 (14.2)
Phase 4 106 (16.6) 5,055 (8.5)
Intervention 
Drug/Biologic 294 (46.1) 44,153 (74.2) <0.001
Procedure 84 (12.7) 5,891 (9.0) 0.01
Device 75 (11.8) 4,581 (7.7) <0.001
Behavioral 125 (19.6) 6,664 (11.2) <0.001
Other 126 (19.8) 10,891 (18.3) 0.28
Randomized 534 (83.4) 34,105(57.3) <0.001
Blinded
Single 129 (20.2) 5,204 (8.7) <0.001
Double 221 (34.6) 17,895 (30.1) 0.04
Sample size <0.001
<50 96 (15.3) 24,693 (43.3)
50-100 118 (21.5) 12,456 (21.9)
>100 414 (63.2) 19,856 (34.8)
Topic
Neurological/Psychiatric 230 (36.1) N/A
Trauma 110 (17.2) N/A
Medical/Surgical 378 (59.3) N/A
Table 1. Characteristics of emergency medicine and non-emergency medicine intervention studies.
US, United States; N/A, not available. 
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EM-funded applications comprised less than 1% of the 2014 
NIH research budget, paling in comparison to funding for sleep 
disorders and rehabilitation research.16,17 
Continuing to develop, expand, and promote the pursuit 
of broad and diverse research within EM may help to boost 
federal funding.18,19 In that regard, we found that subspecialty 
areas were not equally represented among EM trials. Nearly 
60% of these trials examined medical and surgical topics; only 
17% studied trauma. Similarly, Roberts and colleagues (2005) 
reported that few clinical trials are conducted on traumatic 
injuries compared with trials across a range of chronic and 
infectious disease conditions. The authors added that “funding 
for trauma research is less than for almost any other cause of 
human suffering” (p. 1095).20 There are formidable challenges to 
conducting research in the EM setting, including the fast-paced/
high-pressure environment, time constraints, and difficulties 
obtaining consent.21 In research involving trauma patients, these 
challenges may be amplified and contribute to the paucity of 
studies in this area. Increasing and prioritizing funding, as well as 
addressing ethical issues, expanding and creating trauma research 
networks, and developing a standard template for trauma research 
are some suggestions that emerged from the NIH Roundtable on 
Emergency Trauma Research convened to enhance research in 
this field.22 
Of utmost importance is the dissemination of research 
findings. Ross and colleagues point out that when trial results are 
not disseminated, scientific knowledge suffers though potential 
redundancy of studies and inaccuracies about clinical evidence; 
commitment to trial participants is violated; and the investigator’s 
ethical obligation to disseminate findings of studies is unmet.23 In 
our study, overall, EM trials were more likely than non-EM to be 
published at all measured time points. Still, we found that only 
34.1% and 26.1%, of EM and non-EM trials completed between 
2007 and 2013 were published, respectively, when allotting at 
least three years from study completion to publication. These 
findings are largely consistent with those of Huser and Cimino 
who found that 27.8% of their sample of phase 2 or higher studies 
registered in ClinicalTrials.gov had been published within three 
years, when they searched for publications via a unique identifier 
(eg, NCT number or PubMed ID).9 
Huser and Cimino note that their search strategy, similar to 
our method, tends to yield a lower proportion of published works 
Figure 2. Number of trials registered in ClinicalTrials.gov by funding source from February 2000-September 2013.
NIH, National Institutes of Health; US Fed, United States federal.
N
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ls
Completed and published 
studies
Emergency 
medicine
Number (%)
Non-emergency 
medicine
Number (%)
All completed studies 216 22,298
Published in three or more 
years
74 (34.3) 5,788 (26.0)
Missing/incorrect study 
completion date
4 1,619
Completed studies with study 
completion date
211 20,679
Published in three or more 
years
72 (34.1) 5,390 (26.1)
Published within two years 38 (18.0) 2,459 (11.9)
Published within one year 14 (6.6) 903 (4.4)
Table 2. Completed and published emergency medicine and non-
emergency medicine intervention studies included in ClinicalTrials.
gov registry, September 2007-September 2016. 
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than manual article-retrieval methods. Based on studies they 
reviewed, these investigators report that 46%-68% of registered 
trials had published results when searches were conducted 
manually. Given the volume of studies we examined, it was 
not feasible to conduct a comprehensive manual search and we 
recognize that our findings likely underestimate the proportions 
of registered trials that were published. However, our method of 
identifying publications was consistent across EM and non-EM 
studies and should thus have obtained an unbiased comparison 
between these groups. Indeed, our decision to examine 
dissemination of results based on published papers likely avoided 
bias that could have arisen had we relied on results reported in 
the ClinicalTrials.gov database. More non-EM than EM trials 
were phase 2 or higher and investigated a drug or biologic; thus, 
more non-EM than EM trials would have met the definition 
of an applicable clinical trial that requires results reporting in 
ClinicalTrials.gov. 
LIMITATIONS
We limited our study to trials conducted in the US and 
these results may not generalize to studies of trials conducted in 
other countries. In addition, we may have missed some relevant 
trials. First, some trials may have gone unregistered, particularly 
from the inception of the ClinicalTrials.gov registry until 2005 
when the International Committee of Medical Journal Editors 
(ICMJE) began requiring registration for publication in one 
of its journals.14 Second, ICMJE-mandated registration gives 
investigators the option of several online registries (eg, World 
Health Organization International Clinical Trial Registry Platform 
or ClinicalTrials.gov); by limiting our search to ClinicalTrials.
gov, we would have overlooked studies in those registries as well.
Although ICMJE requires investigators to register all trials 
conducted on human subjects, federal law requires registration 
only of studies that are applicable clinical trials (ACTs).12 We 
found that EM trials were less likely than non-EM to be ACTs, 
so more EM than non-EM trials may have gone unregistered. 
In addition, by identifying registered EM trials through search 
words “emergency,” “ER,” “ED,” “EM,” “acute care,” and 
“trauma,” we may have overlooked and misclassified some EM 
trials. Furthermore, we did not formally examine the validity of 
the automatic text classifier that we used to identify EM studies, 
but we did conduct manual reviews of a subset of the articles that 
the text classifier prioritized. 
With respect to classifying EM studies by subspecialty, 
Figure 3. Cumulative incidence for time to publication overall and by funding source, emergency medicine (EM) and non-EM trials.
NIH, National Institutes of Health.
Years
Figure 3a. Cumulative Incidence of Time to Publication
(all funding sources)
Years
Figure 3b. Cumulative Incidence of Time to Publication
(NIH and federally funded)
Years
Figure 3c. Cumulative Incidence of Time to Publication
(industry funded)
Years
Figure 3d. Cumulative Incidence of Time to Publication
(other funding sources)
Log-rank test: p = 0.011 Log-rank test: p < 0.001
Log-rank test: p = 0.095 Log-rank test: p = 0.959
o EM (n=21)
 Non-EM (n=20679) o EM (n=46) Non-EM (n=6003)
o EM (n=125)
 Non-EM (n=4423)
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 Non-EM (n=10244)
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we did examine agreement between our initial two raters of 
EM, but we did not formally compare agreement with a third 
rater subsequently trained by the initial raters. Our use of NCT 
number to identify published studies likely underestimated 
the proportion of published trials; studies that conduct manual 
searches of the PubMed database find a larger proportion of 
published studies. 9 Moreover, we restricted our search for 
publications to MEDLINE, potentially missing published 
works in other online databases such as the Cochrane Library, 
Cumulative Index to Nursing and Allied Health Literature, or 
Excerpta Medica Database.
We collected data on studies registered through September 
27, 2013, and concluded our follow-up of published studies 
in September 2016. It is possible that characteristics of more 
recently registered trials may differ and our data may not 
demonstrate newer trends in research. Future studies should 
examine more recent data and might also extend the follow-up 
for published work. Future studies should also endeavor to assess 
clinical EM research and its progress in relation to other specific 
medical specialties and subspecialties. We compared EM studies 
with non-EM, the latter being a very broad comparator, likely 
with wide-ranging differences in study characteristics and quality 
and publication status by medical specialty. 
CONCLUSION
Given the commitment to expand and advance clinical 
EM research, periodic assessment using quality indicators can 
provide informative quantitative data to assess its progress. This 
study used several key metrics for evaluating EM clinical trials 
including trial quality, funding source, and dissemination of study 
findings. Data for studies completed through September 2013 
and followed for publication through September 2016 indicated 
that the EM portfolio consisted of only 638 trials over the 14-
year study period and that trauma research accounted for only a 
small proportion of EM studies. Further, compared with non-EM 
studies, EM studies were less likely to have received federal or 
industry funding. Nonetheless, the quality of EM trials surpassed 
that of non-EM trials, based on indices such as randomization 
and blinding. This novel finding bodes well for the future and 
advancement of EM research, as does the higher proportion of 
published EM vs non-EM trials. Periodic assessment of EM 
trials with the metrics used here will help to provide a valuable 
longitudinal view of progress in clinical EM research. 
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